Hypertrophic cardiomyopathy part II--anesthetic and surgical considerations

Praveen Kerala Varma1, Suneel Puthuvassery Raman, Praveen Kumar Neema

  • 1Department of Cardiac Surgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Insights

Anesthesia for hypertrophic cardiomyopathy (HCM) requires careful management of preload, heart rate, and afterload to prevent left ventricular outflow tract obstruction. Intraoperative transesophageal echocardiography (TEE) is crucial for diagnosis and surgical assessment.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Cardiac Surgery

Background:

  • Hypertrophic cardiomyopathy (HCM) presents significant anesthetic and surgical challenges.
  • Left ventricular outflow tract (LVOT) obstruction is a primary concern, influenced by preload, heart rate, and afterload.

Purpose of the Study:

  • To review preoperative assessment strategies for patients with HCM undergoing surgery.
  • To outline anesthetic management principles for HCM patients.
  • To highlight the role of transesophageal echocardiography (TEE) in HCM surgery.

Main Methods:

  • Review of existing literature on HCM, anesthesia, and surgical management.
  • Focus on preoperative evaluation, anesthetic conduct, and intraoperative TEE.
  • Discussion of surgical techniques including myectomy, resection, plication, and release.

Main Results:

  • Optimal anesthetic management involves maintaining adequate preload, controlling sympathetic response, managing heart rate, and avoiding increased afterload.
  • TEE is essential for confirming HCM diagnosis, understanding pathophysiology, identifying mitral valve anomalies, and assessing surgical outcomes.

Conclusions:

  • A multidisciplinary approach is vital for successful surgical outcomes in HCM patients.
  • Careful preoperative assessment and tailored anesthetic techniques are critical.
  • Intraoperative TEE provides invaluable real-time guidance for surgical intervention.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
457
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
750
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
788
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
942